Metraipolis › archive › dc_f37e7c3161cc

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials — Europe PMC PMID:41159493

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41159493
DOI
10.1002/advs.202502037
License (as archived)
solo-consultazione
Archived
2026-11-08T23:40:36.694Z
SHA-256 of the archived text
ff4fac8840cbc2d564e64687ae037368ddde6cd895e4f98bb8b658abf50cb74f
Stable URL of this page
https://metraipolis.com/documento/dc_f37e7c3161cc

How to cite

Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials — Europe PMC PMID:41159493 — Europe PMC (en), https://europepmc.org/article/MED/41159493 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f37e7c3161cc (Metraipolis archive dc_f37e7c3161cc, sha256 ff4fac8840cbc2d564e64687ae037368ddde6cd895e4f98bb8b658abf50cb74f)
BibTeX
@misc{dcf37e7c3161cc,
  title = {Predicting Immunotherapy Outcomes in NSCLC Using RNA and Pathology from Multicenter Clinical Trials — Europe PMC PMID:41159493},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41159493},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f37e7c3161cc; sha256 ff4fac8840cbc2d564e64687ae037368ddde6cd895e4f98bb8b658abf50cb74f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41159493. Agents can read the archived copy with the MCP tool read_document.